Clinical outcome of personalised treatment guided by genome and transcriptome sequencing in patients with neuroendocrine neoplasms: Updated results from the German NCT/DKTK MASTER trial

Kreutzfeldt S, Apostolidis L, Oles M, Horak P, Heilig CE, Heining C, Hutter B, Klink B, Lamping M, Uhrig S, Stenzinger A, Winkler EC, Wiedenmann B, Jaeger D, Brors B, Schroeck E, Keilholz U, Pavel ME, Glimm H, Froehling S (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Annals of Oncology Elsevier

Publisher: OXFORD UNIV PRESS

City/Town: OXFORD

Conference Proceedings Title: ANNALS OF ONCOLOGY

Event location: London GB

DOI: 10.1093/annonc/mdz413.023

Authors with CRIS profile

Marianne Ellen Pavel Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

Involved external institutions

Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg DE Germany (DE) Universitätsklinikum Heidelberg DE Germany (DE) Universitätsklinikum Carl Gustav Carus Dresden DE Germany (DE) Deutsches Krebsforschungszentrum (DKFZ) DE Germany (DE) Charité - Universitätsmedizin Berlin DE Germany (DE)

How to cite

APA:

Kreutzfeldt, S., Apostolidis, L., Oles, M., Horak, P., Heilig, C.E., Heining, C.,... Froehling, S. (2019). Clinical outcome of personalised treatment guided by genome and transcriptome sequencing in patients with neuroendocrine neoplasms: Updated results from the German NCT/DKTK MASTER trial. In ANNALS OF ONCOLOGY. London, GB: OXFORD: OXFORD UNIV PRESS.

MLA:

Kreutzfeldt, S., et al. "Clinical outcome of personalised treatment guided by genome and transcriptome sequencing in patients with neuroendocrine neoplasms: Updated results from the German NCT/DKTK MASTER trial." Proceedings of the Conference on Molecular Analysis for Personalised Therapy (MAP), London OXFORD: OXFORD UNIV PRESS, 2019.

BibTeX: Download